Skip to main content

Crossmark Global Holdings, Inc.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1539204 HOUSTON, TX

Position in NBIX

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$1,115,442
-$71,249 QoQ
Shares Held
8,467
+1.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Crossmark Global Holdings, Inc. holds $36,724,175 across 14 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NBIX
Neurocrine Biosciences Inc
This page
8,467 $1,115,442

All Filings in NBIX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,115,442 8,467
2025-12-31 $1,186,691 8,367
2025-09-30 $1,103,106 7,858
2025-06-30 $1,008,285 8,022
2025-03-31 $971,621 8,785
2024-12-31 $1,155,472 8,465
2024-09-30 $977,871 8,487
2024-06-30 $1,002,649 7,283
2024-03-31 $1,095,084 7,940
2023-12-31 $1,061,458 8,056
2023-09-30 $961,537 8,547
2023-06-30 $852,094 9,036
2023-03-31 $952,985 9,415
2022-12-31 $1,099,205 9,203
2022-09-30 $986,265 9,286
2022-06-30 $915,434 9,391
2022-03-31 $889,781 9,491
2021-12-31 $809,200 9,501
2021-09-30 $1,005,232 10,481
2021-06-30 $1,028,769 10,571